High Seroprevalence of Human T-Cell Lymphotropic Virus Type 1 in Blood Donors in Guyana and Molecular and Phylogenetic Analysis of New Strains in the Guyana Shelf (Guyana, Suriname, and French Guiana)

Journal of Clinical Microbiology

Volumn 42, Issue 5, 2004, Pages 2020-2026

  Pouliquen, Jean François ^a   Hardy, Lynette ^b   Lavergne, Anne ^a   Kafiludine, Eric ^c   Kazanji, Mirdad ^a,d  

^a INSTITUT PASTEUR DE LA GUYANE   (French Guiana)

^b National Blood Transfusion Service   (Guyana)

^c ACADEMIC HOSPITAL PARAMARIBO   (Suriname)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRENCH GUIANA; GUYANA; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEROPREVALENCE; SURINAME; VIRUS IDENTIFICATION; VIRUS STRAIN; WESTERN BLOTTING;

ADULT; AGED; BLOOD DONORS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FRENCH GUIANA; GENES, ENV; GUYANA; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES; SURINAME;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; RNA VIRUSES;

EID: 2442526663     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.5.2020-2026.2004     Document Type: Article

References (50)

1. Alberga, H., P. Goubau, J. Desmyter, and H. Carton. 1996. Prevalence of human T-lymphotropic virus, type 1 and 2 in blood donors and patients with sexually transmissible diseases in Surinam. Ned. Tijdschr. Geneeskd. 140: 1689-1692.
2. Biggar, R. J., M. E. Taylor, J. V. Neel, B. Hjelle, P. H. Levine, F. L. Black, G. M. Shaw, P. M. Sharp, and B. H. Hahn. 1996. Genetic variants of human T-lymphotrophic virus type II in American Indian groups. Virology 216:165-173.
3. Biglione, M., O. Vidan, R. Mahieux, M. de Colombo, M. de Los Angeles, A. de Basualdo, M. Bonnet, G. Pankow, M. Avila de Efron, A. Zorrilla, F. Tekaia, E. Murphy, G. de Thé, and A. Gessain. 1999. Seroepidemiological and molecular studies of HTLV-II, subtype b, in isolated groups of Mataco and Toba Indians of northern Argentina. AIDS Res. Hum. Retrovir. 15:407-417.
4. Blattner, W., C. Saxinger, D. Riedel, B. Hull, G. Taylor, F. Cleghorn, R. Gallo, B. Blumberg, and C. Bartholomew. 1990. A study of HTLV-I and its associated risk factors in Trinidad and Tobago. J Acquir. Immune. Defic. Syndr. 3:1102-1108.
5. Cesaire, R., O. Bera, H. Maier, A. Lezin, J. Martial, M. Ouka, B. Kerob-Bauchet, A. Ould Amar, and J. Vernant. 1999. Seroindeterminate patterns and seroconversions to human T-lymphotropic virus type I positivity in blood donors from Martinique, French West Indies. Transfusion 39:1145-1149.
6. Daisley, H., W. Charles, P. Landeau, L. Jackman, M. Batson, and K. Gomez-Adams. 1991. Screening for HTLV-1 in healthy blood donors in Trinidad and Tobago, West Indies. Trop. Med. Parasitol. 42:404-406.
7. de Oliveira Mdo, S., N. Hamerschlak, C. Chiattone, and P. Loureiro. 1996. HTLV-I infection and adult T-cell leukemia in Brazil: an overview. Rev. Paul. Med. 114:1177-1185.
8. de Thé, G., and A. Gessain. 1986. Seroepidemiologic data on viral infections (HTLV-I and LAV/HTLV-III) in the Caribbean region and intertropical Africa. Ann. Pathol. 6:261-264.
9. Fouchard, N., B. Flageul, M. Bagot, M. F. Avril, O. Hermine, F. Sigaux, H. Merle-Beral, X. Troussard, J. F. Delfraissy, G. de Thé, and A. Gessain. 1995. Lack of evidence of HTLV-I/II infection in T CD8 malignant or reactive lymphoproliferative disorders in France: a serological and/or molecular study of 169 cases. Leukemia 9:2087-2092.
10. Gerard, Y., J. F. Lepere, R. Pradinaud, F. Joly, L. Lepelletier, M. Joubert, D. Sainte Marie, R. Mahieux, A. U. Vidal, D. Larregain-Fournier, F. Valensi, D. Moynet, G. de Thé, B. Guillemain, J. P. Moreau, and A. Gessain. 1995. Clustering and clinical diversity of adult T-cell leukemia/lymphoma associated with HTLV-I in a remote black population of French Guiana. Int. J. Cancer 60:773-776.
11. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de Thé. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410.
12. Gessain, A., R. C. Gallo, and G. Franchini. 1992. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J. Virol. 66:2288-2295.
13. Gessain, A., R. Mahieux, and G. de Thé. 1996. Genetic variability and molecular epidemiology of human and simian T cell leukemia/lymphoma virus type I. J. Acquir. Immune. Defic. Syndr. Hum. Retrovir. 13(Suppl. 1): S132-S145.
14. Gessain, A., L. Meertens, and R. Mahieux. 2002. Molecular epidemiology of human T cell leukemia/lymphoma viruses type 1 and type 2 (HTLV-1/2) and related simian retroviruses (STLV-1, STLV-2 and STLV-L/3), p. 121-165. In T. Leitner (ed.), The molecular epidemiology of human viruses, vol. 7. Kluwer Academic Publishers, Boston, Mass.
15. Gotuzzo, E., C. Arango, A. deq Ueiroz-Campos, and R. E. Isturiz. 2000. Human T cell lymphotropic virus-I in Latin America. Infect. Dis. Clin. N. Am. 14:211-239.
16. Hjelle, B., O. Appenzeller, R. Mills, S. Alexander, N. Torrezmartinez, R. Jahnke, and G. Ross. 1992. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 339:645-646.
17. Hjelle, B., R. Mills, S. Swenson, G. Mertz, C. Key, and S. Allen. 1991. Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J. Infect. Dis. 163: 435-440.
18. Ijichi, S., T. Matsuda, I. Maruyama, T. Izumihara, K. Kojima, T. Niimura, Y. Maruyama, S. Sonoda, A. Yoshida, and M. Osame. 1990. Arthritis in a human T-lymphotropic virus type-I (HTLV-I) carrier. Ann. Rheum. Dis. 49:718-721.
19. Inaba, S., K. Okochi, H. Sato, K. Fukada, N. Kinukawa, H. Nakata, K. Kinjyo, F. Fujii, and Y. Maeda. 1999. Efficacy of donor screening for HTLV-I and the natural history of transfusion-transmitted infection. Transfusion 39:1104-1110.
20. Kaplan, J., R. Khabbaz, E. Murphy, S. Hermansen, C. Roberts, R. Lal, W. Heneine, D. Wright, L. Matijas, R. Thomson, D. Rudolph, W. Switzer, S. Kleinman, M. Busch, G. Schreiber, et al. 1996. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. J. Acquir. Immune. Defic. Syndr. 12:193-201.
21. Kazanji, M., B. Benoit, M. Meddeb, L. Meertens, C. Marty, A. Gessain, and A. Talarmin. 2001. Molecular characterization and phylogenetic analysis of a human T cell leukemia virus type 2 strain from French Guiana. AIDS Res. Hum. Retrovir. 17:563-568.
22. Lagrenade, L., B. Hanchard, V. Fletcher, B. Cranston, and W. Blattner. 1990. Infective dermatitis of Jamaican children-a marker for HTLV-I infection. Lancet 336:1345-1347.
23. Mahieux, R., A. Gessain, A. Truffert, D. Vitrac, A. Hubert, J. Dandelot, C. Montchamp-Moreau, F. Cnudde, F. Tekaia, and G. de Thé. 1994. Seroepidemiology, viral isolation, and molecular characterization of human T cell leukemia/lymphoma virus type I from La Reunion Island, Indian Ocean. AIDS Res. Hum. Retrovir. 10:745-752.
24. Mahieux, R., F. Ibrahim, P. Mauclere, V. Herve, P. Michel, F. Tekaia, C. Chappey, B. Garin, E. van der Ryst, B. Guillemain, E. Ledru, E. Delaporte, G. de Thé, and A. Gessain. 1997. Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in pygmies. J. Virol. 71:1317-1333.
25. Manns, A., M. Hisada, and L. La Grenade. 1999. Human T-lymphotropic virus type I infection. Lancet 353:1951-1958.
26. Manns, A., R. Wilks, E. Murphy, G. Haynes, J. Figueroa, M. Barnett, B. Hanchard, and W. Blattner. 1992. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int. J. Cancer 51:886-891.
27. Massari, V., M. H. Elghouzzi, F. Agis, C. Rannou, E. Gordien, D. Costagliola, and J. J. Lefrere. 1994. Epidemiologic comparison of human T-lymphotropic virus type I-infected blood donors from endemic and nonendemic regions over a 3-year period. Transfusion 34:198-201.
28. Mochizuki, M., K. Yamaguchi, K. Takatsuki, T. Watanabe, S. Mori, and K. Tajima. 1992. HTLV-I and uveitis. Lancet 339: 1110.
29. Morgan, O., P. Rodgers-Johnson, C. Mora, and G. Char. 1989. HTLV-I and polymyositis in Jamaica. Lancet ii:1184-1186.
30. Murphy, E., K. Watanabe, C. Nass, H. Ownby, A. Williams, and G. Nemo. 1999. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States. J. Infect. Dis. 180:1777-1783.
31. Murphy, E. L., J. Fridey, J. W. Smith, J. Engstrom, R. A. Sacher, K. Miller, J. Gibble, J. Stevens, R. Thomson, D. Hansma, J. Kaplan, R. Khabbaz, G. Nemo, et al. 1997. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. Neurology 48:315-320.
32. Murphy, E. L., R. Mahieux, G. de Thé, F. Tekaia, D. Ameti, J. Horton, and A. Gessain. 1998. Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: an age-cohort effect for HTLV-II RFLP type aO. Virology 242:425-434.
33. Pardi, D., W. M. Switzer, K. G. Hadlock, J. E. Kaplan, R. B. Lal, and T. M. Folks. 1993. Complete nucleotide sequence of an Amerindian human T-cell lymphotropic virus type II (HTLV-II) isolate: identification of a variant HTLV-II subtype b from a Guaymi Indian. J. Virol. 67:4659-4664.
34. Philippe, H. 1993. MUST, a computer package of management utilities for sequences and trees. Nucleic Acids Res. 21:5264-5272.
35. Plancoulaine, S., R. P. Buigues, E. Murphy, M. Van Beveren, J. F. Pouliquen, M. Joubert, F. Remy, P. Tuppin, P. Tortevoye, G. de Thé, J. P. Moreau, and A. Gessain. 1998. Demographic and familial characteristics of HTLV-I infection among an isolated, highly endemic population of African origin in French Guyana. Int. J. Cancer 76:331-336.
36. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
37. Rouet, F., C. Foucher, M. Rabier, I. Gawronski, D. Taverne, B. Chancerel, O. Casman, and M. Strobel. 1999. Human T-lymphotropic virus type I among blood donors from Guadeloupe: donation, demographic, and biologic characteristics. Transfusion 39:639-644.
38. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
39. Salemi, M., A. Vandamme, C. Gradozzi, K. Van Laethem, E. Cattaneo, G. Taylor, C. Casoli, P. Goubau, J. Desmyter, and U. Bertazzoni. 1998. Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from European injecting drug users. J. Mol. Evol. 46:602-611.
40. Schwebke, J., D. Calsyn, K. Shriver, A. Saxon, J. Kleyn, E. Oluoch-Mitchell, L. Olmstead, L. D. Fisher, M. Krone, R. Ashley, W. Stamm, P. Swenson, and K. K. Holmes. 1994. Prevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users. J. Infect. Dis. 169:962-967.
41. Shindo, N., L. C. Alcantara, S. van Dooren, M. Salemi, C. M. C., S. Kashima, D. T. Covas, A. Teva, M. Pellegrini, I. Brito, A. M. Vandamme, and B. Galvao-Castro. 2002. Human retroviruses (HIV and HTLV) in Brazilian Indians: seroepidemiological study and molecular epidemiology of HTLV type 2 isolates. AIDS Res. Hum. Retrovir. 18:71-77.
42. Sullivan, M., A. Williams, C. Fang, E. Notari, B. Poiesz, G. Ehrlich, et al. 1993. Human T-lymphotropic virus (HTLV) types I and II infection in sexual contacts and family members of blood donors who are seropositive for HTLV type I or II. Transfusion 33:585-590.
43. Switzer, W. M., F. L. Black, D. Pieniazek, R. J. Biggar, R. B. Lal, and W. Heneine. 1996. Endemicity and phylogeny of the human T cell lymphotropic virus type II subtype A from the Kayapo Indians of Brazil: evidence for limited regional dissemination. AIDS Res. Hum. Retrovir. 12:635-640.
44. Switzer, W. M., S. M. Owen, D. A. Pieniazek, V. R. Nerurkar, E. Duenas-Barajas, W. Heneine, and R. B. Lal. 1995. Molecular analysis of human T-cell lymphotropic virus type II from Wayuu Indians of Colombia demonstrates two subtypes of HTLV-IIb. Virus Genes 10:153-162.
45. Takezaki, T., K. Tajima, H. Komoda, and J. Imai. 1995. Incidence of human T lymphotropic virus type I seroconversion after age 40 among Japanese residents in an area where the virus is endemic. J. Infect. Dis. 171:559-565.
46. Talarmin, A., B. Vion, A. Ureta-Vidal, G. Du Fou, C. Marty, and M. Kazanji. 1999. First seroepidemiological study and phylogenetic characterization of human T-cell lymphotropic virus type I and II infection among Amerindians in French Guiana. J. Gen. Virol. 80:3083-3088.
47. Touze, E., A. Gessain, O. Lyon-Caen, and O. Gout. 1996. Tropical spastic paraparesis/HTLV-I-associated myelopathy in Europe and in Africa: clinical and epidemiologic aspects. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1):S38-S45.
48. Vandamme, A. M., H. F. Liu, P. Goubau, and J. Desmyter. 1994. Primate T-lymphotropic virus type I LTR sequence variation and its phylogenetic analysis: compatibility with an African origin of PTLV-I. Virology 202:212-223.
49. Van Dooren, S., E. Gotuzzo, M. Salemi, D. Watts, E. Audenaert, S. Duwe, H. Ellerbrok, R. Grassmann, E. Hagelberg, J. Desmyter, and A. M. Vandamme. 1998. Evidence for a post-Columbian introduction of human T-cell lymphotropic virus in Latin America. J. Gen. Virol. 79:2695-2708.
50. Yamashita, M., G. Picchio, R. Veronesi, S. Ohkura, P. Bare, and M. Hayami. 1998. HTLV-Is in Argentina are phylogenetically similar to those of South American countries, different from HTLV-Is in Africa. J. Med. Virol. 55: 152-160.